Pomalyst (pomalidomide)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Pomalyst (pomalidomide), covering 2025-04-30 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma [Phase 2]